Page last updated: 2024-11-03

opc 12759 and Proctitis

opc 12759 has been researched along with Proctitis in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Proctitis: INFLAMMATION of the MUCOUS MEMBRANE of the RECTUM, the distal end of the large intestine (INTESTINE, LARGE).

Research Excerpts

ExcerptRelevanceReference
" Enemas containing 150 mg rebamipide per dosing were administered after morning bowel movement, and always prior to bedtime, twice daily for 4 weeks."2.73Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed. ( Cho, M; Heo, J; Kang, DH; Kim, GH; Kim, TO; Lee, SM; Song, GA, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, TO1
Song, GA1
Lee, SM1
Kim, GH1
Heo, J1
Kang, DH1
Cho, M1
Makiyama, K1
Takeshima, F1
Kawasaki, H1
Zea-Iriarte, WL1

Trials

1 trial available for opc 12759 and Proctitis

ArticleYear
Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed.
    International journal of colorectal disease, 2008, Volume: 23, Issue:6

    Topics: Aged; Alanine; Antioxidants; Enema; Female; Genital Neoplasms, Female; Humans; Middle Aged; Proctiti

2008

Other Studies

1 other study available for opc 12759 and Proctitis

ArticleYear
Anti-inflammatory effect of rebamipide enema on proctitis type ulcerative colitis: a novel therapeutic alternative.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:7

    Topics: Adult; Alanine; Anti-Ulcer Agents; Colitis, Ulcerative; Enema; Female; Humans; Proctitis; Quinolones

2000